Iterum TherapeuticsITRMF
13F holders, Q1 2024 (March 31)2holders
$1.55avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings. The largest holders were Blue Bell Private Wealth Management, LLC ($102) and Ancora Advisors LLC ($59).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L101
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $102 |
| Exits | 1 | $130 |
Ownership 2 holders
| Blue Bell Private Wealth Management, LLC | 0.00% | New | 66 | $102 |
| Ancora Advisors LLC | 0.00% | No change | 38 | $59 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.